Official: Deportivo Alavés star seals €16m Ligue 1 switch
This comes after attacker Joaquín Panichelli's long-rumoured departure from the club was finally made official.
Panichelli, for his part, spent this past season out on loan away from Alavés.
Not yet considered ready to be a regular contributor at Mendizorroza, the Argentine made the move to Spain's 2nd tier, with CD Mirandés.
And to say that Panichelli went on to enjoy a productive stint on the books of Mirandés would be putting it lightly…
All told, across 44 appearances in La Liga 2, the 22-year-old racked up a head-turning 29 direct goal contributions.
Such exploits did not go unnoticed across the continent, with Ligue 1 outfit Strasbourg, for one, having recently opened talks with their Alavés counterparts in an effort to beat out the stiff competition for Panichelli's signature.
And as alluded to above, this weekend, such negotiations have officially borne fruit.
As per a statement across Alavés' website and social media platforms on Sunday:
'Deportivo Alavés and RC Strasbourg Alsace have reached an agreement for the transfer of striker Joaquín Panichelli to the French club.'
According to transfer insider , Panichelli's move to France has come at a cost of around €16.5 million.
Conor Laird – GSFN
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Cell and Gene Therapy Supply Chain Software Market Report 2025-2035: 170+ Software Solutions Providers Fueling Fragmented Cell & Gene Therapy Supply Chain Market Growth
The global cell and gene therapy supply chain software market is set to expand from USD 0.27 billion in 2025 to USD 1.32 billion by 2035, at a CAGR of 15.2%. Driven by demand for advanced therapies, the market is enhanced by cloud-based technologies and key players like Azenta Life Sciences and Lonza. Cell and Gene Therapy Supply Chain Dublin, July 28, 2025 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy Supply Chain Software Market: Industry Trends and Global Forecasts to 2035: Distribution by Process Component, Type of Software, Mode of Deployment, Scale of Operation, Type of End-user and Key Geographical Regions" report has been added to offering. The global cell and gene therapy supply chain software market is estimated to grow from USD 0.27 billion in 2025, to USD 1.32 billion by 2035, at a CAGR of 15.2% during the forecast period, to 2035. CELL AND GENE THERAPY SUPPLY CHAIN SOFTWARE MARKET: GROWTH AND TRENDS Advanced therapies are gradually evolving the face of modern healthcare. These new regenerative and immunotherapy modalities have the potential to improve treatment outcomes by providing viable therapy solutions to patients who currently have limited or no treatment options. Given the nature of these treatment modalities, these therapies have a limited lifespan, even when shipped under temperature-controlled conditions. It becomes increasingly important to track the source of the sample from the time of its collection, current location and manufacturing processes. Following this fact, for the commercial success of such therapies, an effective manufacturing platform and a robust supply chain model are imperative. It is worth mentioning that a sustainable supply chain enables further reductions in the cost of goods and, in turn, prices of such therapies. The supply chain for innovative therapies is complicated from the outset and given the interdependencies amongst multiple stakeholders, it becomes challenging to manage and streamline the overall process. This has reinforced the need for bespoke and integrated software solutions to help innovators manage the critical intricacies of the supply chain. These software systems have huge potential to manage a multitude of events, maintain the chain of identity and custody, and enable stakeholders to optimize the complex supply chains, while also ensuring compliance with global regulatory standards. Driven by the growing demand for cell and gene therapies and the availability of easy to integrate software solutions to manage cell and gene therapy supply chain, this market is expected to grow significantly in the foreseen future. CELL AND GENE THERAPY SUPPLY CHAIN SOFTWARE MARKET: KEY INSIGHTS The report delves into the current state of the cell and gene therapy supply chain software market and identifies potential growth opportunities within the industry. Some key findings from the report include: Presently, close to 175 cell and gene therapy supply chain software solutions are available in the market; of these, 22% are laboratory information management systems. Over 20% of the cell and gene therapy supply chain software solutions can be deployed both on-premises and over the cloud, offering flexibility as well as contact-less options for the end-users. The current market landscape of cell and gene therapy supply chain software providers is fragmented, featuring the presence of both new entrants and established players; majority of these players are based in the US. The growing interest in this domain is evident from the rise in partnership activity; in fact, 40 partnership deals related to cell and gene therapy supply chain software were inked in 2023. Several investors, having realized the opportunities associated within supply chain management software domain, have invested USD 3 billion across various funding rounds in the past 10 years. Driven by the increasing pace of innovation and partnership activity, the market for cell and gene therapy supply chain software is poised to witness steady growth in the foreseeable future. The cell and gene therapy supply chain software market is anticipated to grow at a CAGR of 15.2%, till 2035; North America is expected to capture the majority share (over 45%) of the market by 2035. CELL AND GENE THERAPY SUPPLY CHAIN SOFTWARE MARKET: RESEARCH COVERAGE Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the cell and gene therapy supply chain software market, focusing on key market segments, including process component, type of software, mode of deployment, scale of operation and key geographical regions. Market Landscape: A comprehensive evaluation of cell and gene therapy supply chain software solutions, considering various parameters, such as type of software, key features, application area, mode of deployment, scale of operation, regulatory guidelines followed and type of end-user. Additionally, it includes a detailed list of developers providing cell and gene therapy supply chain software solutions, along with analysis based on various parameters, such as year of establishment, company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific, and rest of the world) and most active players based on the number of software solutions offered. Company Competitiveness Analysis: A comprehensive competitive analysis of cell and gene therapy supply chain software solution providers, examining factors, such as developer strength and product portfolio strength. Company Profiles: In-depth profiles of key cell and gene therapy supply chain software solution providers, focusing on company overviews, software solutions portfolio, financial information, recent developments and an informed future outlook. Funding and Investment Analysis: A detailed evaluation of the investments made in this domain, encompassing seed funding, venture capital, debt financing, grants / awards, capital raised from IPOs and subsequent offerings. Partnerships and Collaborations: An analysis of partnerships established in this sector, since 2019, covering acquisitions, platform utilization agreements, service alliances, platform integration agreements, product development agreements, service agreements and other agreements. Platform Utilization Agreements in Supply Chain Software Solutions Market: An in-depth analysis of the platform utilization agreements inked in this domain since 2019, providing information on the different types of software utilized by end-users in the cell and gene therapy supply chain. Stakeholder Need Analysis: A qualitative evaluation of the current and future needs of various stakeholders in the cell and gene therapy supply chain, including patients, healthcare providers, collection centers, manufacturers, logistics service providers and regulators. This section provides a summary of the distinct needs of these stakeholders and presents our opinion (drawn from historical and current trends) on the impact of these needs on the supply chain and how the industry is preparing to cater to these needs. Market Impact Analysis: The report analyzes various factors such as drivers, restraints, opportunities, and challenges affecting the market growth. Sample Players in the Cell and Gene Therapy Supply Chain Software Market, Profiled in the Report Include: Azenta Life Sciences Biocair BioLife Solutions CareDx Cryoport Lonza NMDP BioTherapies TraceLink TrakCel Veeva Systems Emerson LabVantage Solutions Marken MasterControl QuickSTAT Siemens Stafa Cellular Therapy Steiner STEMSOFT Software TECHNIDATA Thermo Fisher Scientific KEY QUESTIONS ANSWERED IN THIS REPORT How many companies are currently engaged in this market? Which are the leading companies in this market? What kind of partnership models are commonly adopted by industry stakeholders? What are the factors that are likely to influence the evolution of this market? What is the current and future market size? What is the CAGR of this market? How is the current and future market opportunity likely to be distributed across key market segments? REASONS TO BUY THIS REPORT The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants. Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies. The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects. ADDITIONAL BENEFITS Complimentary PPT Insights Packs Complimentary Excel Data Packs for all Analytical Modules in the Report 10% Free Content Customization Detailed Report Walkthrough Session with Research Team For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Cell and Gene Therapy Supply Chain CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
Yahoo
15 minutes ago
- Yahoo
Al-Nassr submit offer to sign Manchester United's Antony
Al-Nassr have made an official approach to sign Manchester United winger Antony (Foot Mercato). The Saudi Pro League side club looking to bring in fresh faces to help new manager Jorge Jesus compete strongly across all fronts next season. They are close to landing Chelsea's forward Joao Felix, and he could team up with Antony in Saudi Arabia. Al-Nassr aim to add more firepower to their attack Antony joined United for €100 million in 2022, but he failed to impress. Despite making a bright start, the winger struggled to keep his place in the side. He was sent on loan to Spanish side Real Betis and helped them reach the final of the Europa Conference League. Antony showed flashes of the quality that earned him a big-money move from Ajax. The 25-year-old ended the season with 10 goals and five assists across all competitions, regaining some confidence in the process. However, United manager Ruben Amorim has no place for the winger in his long-term plans. The Red Devils are now open to letting the Brazilian leave, and Al-Nassr could be a potential destination. There is no clarity on the fee being offered by the Saudi club, but United are expected to seriously consider a deal.
Yahoo
15 minutes ago
- Yahoo
Watch BMX Racing World Championships on BBC
British riders will be taking to the track at the BMX Racing World Championships in Copenhagen this week and BBC Sport will be showing all the action on Sunday, 3 August when the rainbow jersey winners are crowned. The last time the World Championships were held in Denmark 14 years ago, Frenchman Joris Daudet claimed his first world title during a dominant year in which he won all 11 rounds on the European BMX tour. He is the defending champion this year and also the reigning Olympic champion after his victory at Paris 2024. The competition is different to 14 years ago, with the races now faster, corners on the course higher and the bike designs different. Who are the ones to watch? Women's races: Australian Saya Sakakibara is the Olympic champion and a two-time World Cup champion. She is on track for a third World Cup victory and will be looking to add the World Championship to her titles, but fourth is the highest she has managed to finish in this event. Zoe Claessens will be looking to go one better than last year when she finished second behind American Alise Willoughby. The Swiss rider is number one in this season's rankings and won bronze at the Paris Olympics. Great Britain's Beth Shriever is an Olympic gold medallist and heads to Denmark in pursuit of a third world title. In the women's Under-23 race, Great Britain's Emily Hutt is the name to look out for. She has finished second in the last two U23 World Championships and will be looking to claim the title for the first time. Men's races: France's Joris Daudet is the man to beat. His win last year at Rock Hill in the United States secured his fourth world title. His compatriot Sylvain Andre will be looking to continue a successful year. Andre is top of both the men's elite rankings and World Cup standings. However, he has not won the World Championship title since 2018. Ross Cullen is the highest-ranked Briton in this season's competition. He won round four of the World Cup and is sixth in the individual rankings. No British cyclist has been the men's world champion since Liam Phillips in 2013. BMX Racing World Championships - BBC schedule Sunday, 3 August - 10:50-14:00 BST on BBC iPlayer, BBC Sport website and app
